R. Manev

发表

Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease

H. Manev, Hu Chen, S. Dzitoyeva, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus

H. Manev, R. Manev, Zhijing Zhang, 2003, Neuroscience Letters.

Aminoglycoside antibiotics and autism: a speculative hypothesis

H. Manev, R. Manev, 2001, BMC psychiatry.

Photochemical stroke and brain‐derived neurotrophic factor (BDNF) mRNA expression

D. Guidolin, H. Manev, R. Manev, 1992, Neuroreport.

Depression with Panic Episodes and Coronary Vasospasm

R. Manev, M. Vidovich, Aneet Y Ahluwalia, 2009, Cardiovascular psychiatry and neurology.

Pharmacological Probing of Type 1 Autism

H. Manev, R. Manev, 2008, Journal of autism and developmental disorders.

Caffeic acid attenuates the decrease of cortical BDNF transcript IV mRNA induced by swim stress in wild-type but not in 5-lipoxygenase-deficient mice

H. Manev, S. Dzitoyeva, R. Manev, 2008, Journal of Neural Transmission.

Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus

H. Manev, R. Manev, T. Uz, 2003, Neuroreport.

Nomen est Omen : do antidepressants increase p 11 or S 100 A 10 ?

H. Manev, R. Manev, 2015 .

Olanzapine and S100 Proteins

H. Manev, R. Manev, 2006, Neuropsychopharmacology.

Nomen est Omen: do antidepressants increase p11 or S100A10?

H. Manev, R. Manev, 2006, Journal of biomedical discovery and collaboration.

Could treatment with arundic acid (ONO-2506) increase vulnerability for depression?

H. Manev, R. Manev, 2006, Medical hypotheses.

5-Lipoxygenase as a Putative Mechanism of NSAID-Related Psychiatric Adverse Events

H. Manev, R. Manev, 2012, Drugs.

Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors

H. Manev, R. Manev, M. Imbesi, 2008, Neuroscience Letters.

Photoisomerization of fluvoxamine generates an isomer that has reduced activity on the 5-hydroxytryptamine transporter and does not affect cell proliferation.

H. Manev, R. Manev, P. Giusti, 2002, European journal of pharmacology.

Is the heterologous expression of metabotropic glutamate receptors (mGluRs) an appropriate method to study the mGluR function? Experience with human embryonic kidney 293 cells transfected with mGluR1

H. Manev, R. Manev, N. Gabellini, 1994, Neurochemistry International.

Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice

H. Manev, R. Manev, M. Imbesi, 2008, Neuroscience Letters.

Minocycline, schizophrenia and GluR1 glutamate receptors

H. Manev, R. Manev, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Functional evidence for a l-AP3-sensitive metabotropic receptor different from glutamate metabotropic receptor mGluR1

H. Manev, R. Manev, N. Gabellini, 1993, Neuroscience Letters.

Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.

A. Rush, A. Nierenberg, S. Wisniewski, 2005, The Journal of clinical psychiatry.

5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease.

H. Manev, R. Manev, Hari Manev, 2006, Medical hypotheses.

The meaning of mammalian adult neurogenesis and the function of newly added neurons: the "small-world" network.

H. Manev, R. Manev, Hari Manev, 2005, Medical hypotheses.

Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro.

N. Smalheiser, H. Manev, R. Manev, 2001, European journal of pharmacology.

Effects of cocaine in 5-lipoxygenase-deficient mice

H. Manev, R. Manev, M. Maccarrone, 2008, Journal of Neural Transmission.

Neurogenesis and Neuroprotection in the Adult Brain

H. Manev, R. Manev, Zhijing Zhang, 2001, Annals of the New York Academy of Sciences.

Glia as a putative target for antidepressant treatments.

H. Manev, R. Manev, T. Uz, 2003, Journal of affective disorders.

5-Lipoxygenase inhibitor MK-886 increases GluR1 phosphorylation in neuronal cultures in vitro and in the mouse cortex in vivo

H. Manev, R. Manev, M. Imbesi, 2007, Brain Research.

Possible role for interactions between 5-lipoxygenase (5-LOX) and AMPA GluR1 receptors in depression and in antidepressant therapy.

H. Manev, R. Manev, D. Mrazovac, 2007, Medical hypotheses.

Fluoxetine increases the content of neurotrophic protein S100beta in the rat hippocampus.

H. Manev, R. Manev, T. Uz, 2001, European journal of pharmacology.

The pattern of melatonin receptor expression in the brain may influence antidepressant treatment.

H. Manev, R. Manev, M. Imbesi, 2007, Medical hypotheses.

5-Lipoxygenase in the Prefrontal Cortex of Suicide Victims.

Yogesh K. Dwivedi, R. Conley, R. Roberts, 2008, The open neuropsychopharmacology journal.

Interactions with GluR1 AMPA receptors could influence the therapeutic usefulness of minocycline in ALS

H. Manev, R. Manev, 2009, Amyotrophic Lateral Sclerosis.

5-lipoxygenase as a possible biological link between depressive symptoms and atherosclerosis.

H. Manev, R. Manev, 2007, Archives of general psychiatry.

Depression, inflammation, and cardiovascular disease: is 5-lipoxygenase the missing link?

H. Manev, R. Manev, M. Vidovich, 2008, Journal of the American College of Cardiology.

Possible genetic predisposition to cardiac effects

H. Manev, R. Manev, Radmila M Manev, 2005, The Medical journal of Australia.

5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders.

H. Manev, R. Manev, 2004, Critical reviews in neurobiology.

Benefits of Neuropsychiatric Phenomics: Example of the 5-Lipoxygenase-Leptin-Alzheimer Connection

H. Manev, R. Manev, Hari Manev, 2010, Cardiovascular psychiatry and neurology.

Commentary Beneﬁts of Neuropsychiatric Phenomics: Example of the 5-Lipoxygenase-Leptin-Alzheimer Connection

H. Manev, R. Manev, 2022 .